Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients

Clinical Colorectal Cancer(2021)10.1016/j.clcc.2021.09.008Source: DataRank Database

Impact of Relative Dose Intensity of FOLFOX Adjuvant Chemotherapy on Risk of Death Among Stage III Colon Cancer Patients is a research paper published in Clinical Colorectal Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.65)OA: hybridTopics (34)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Trevor Thompson ORCID,Hui‐Yi Lin ORCID,Vivien W. Chen ORCID,Jordan J. Karlitz ORCID,Elizabeth T. H. Fontham

Live enrichment

PubMed:34756680 PMC:PMC8971135 OpenAlex:https://openalex.org/W3114004769

Intramural CDC HHS

Grant: CC999999

NCI NIH HHS

Grant: HHSN261201300016I

NCCDPHP CDC HHS

Grant: U58 DP000792

LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER

FWCI

0.65

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.clcc.2021.09.008

publisherhttps://doi.org/10.1016/j.clcc.2021.09.008

publisherhttps://api.elsevier.com/content/article/PII:S1533002821000943?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1533002821000943?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34756680

Fields of Study

Colorectal Cancer Surgical TreatmentsColorectal Cancer Treatments and StudiesColorectal Cancer Screening and DetectionAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantColonic NeoplasmsHumansNeoplasm StagingProportional Hazards ModelsRetrospective Studies

MeSH Terms

Antineoplastic Combined Chemotherapy ProtocolsColonic NeoplasmsHumansNeoplasm StagingRetrospective StudiesProportional Hazards ModelsChemotherapy, Adjuvant

Keywords

FOLFOXMedicineColorectal cancerOncologyStage (stratigraphy)Adjuvant chemotherapyInternal medicineChemotherapyOxaliplatinCancerAdjuvantBreast cancerMortalityChemotherapy ToxicityTailored ChemotherapyHigh-risk Stage IiiLow-risk Stage Iii

Sustainable Development Goals

SDG 0: Good health and well-being